Literature DB >> 32327314

COVID-19, mobile health and serious mental illness.

John Torous1, Matcheri Keshavan2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32327314      PMCID: PMC7161497          DOI: 10.1016/j.schres.2020.04.013

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


× No keyword cloud information.
As the COVID-19 global pandemic rapidly expands, the potential of digital health for mental health has become urgently apparent. The surge in interest and use of digital health to meet the demands of patients in quarantine, with social and physical distancing restrictions, and a lack of in-person care has centered on anxiety and depression – and largely ignored those with serious mental illnesses (SMI) such as psychotic disorders. Adapting digital health to the needs of SMI patients is an emergent need. Initial reports suggest the mental health of patients with COVID-19 are being poorly handled (Duan and Zhu, 2020); few implementation efforts around psychological interventions had been completed in China and strict infection measures limited access to mental health providers. In place of traditional care, online mental health resources were utilized in China (Liu et al., 2020) although none appear specifically designed or tested for use in clinic care. Already in the United States there have been changes around telehealth with federal regulations temporarily permitting unprecedented access through non-secure platforms and across state lines. This willingness to embrace digital health, especially telehealth, is common in disasters. Patients with schizophrenia may have higher levels of avoidance coping and report overall reduced coping ability, self-esteem, and social support than the general population in disaster settings (Horan et al., 2007). This higher avoidance may lead to more stress later. Patients with schizophrenia under- report their physical health symptoms (Sonoda et al., 2019). Patients with SMI may react to disaster and uncertainties with heightened anxiety, and social distancing could contribute to isolation and worsening depression. SMI Patients also may have cognitive limitations posing challenges to appropriately handle the informational overload in times of crises; tele/digital health can address cognitive deficits (Guimond et al., 2019). Telehealth can meet these mental health needs of patients with SMI (Krzystanek et al., 2017) though issues of access present new opportunities and challenges for the field. Smartphones may be an effective way to implement telepsychiatry services in people with SMI. Telepsychiatry requires camera, internet connection, and computer all integrated into a single device – such integration is feasible via smartphones for most patients. Patients with schizophrenia are more likely to have a phone than computer (Aschbrenner et al., 2018) with nearly 50% of people with schizophrenia owning a smartphone in 2015 (Young et al., 2019) and 66% in 2018 (Torous et al., 2018). Considering that even in the general population 37% of adults access the internet primarily via smartphones and 58% for those ages 18 to 29 according to Pew data from 2019 – it is clear that telehealth cannot be separated from mobile health and smartphones. Several opportunities are emerging for improving care via smartphones. This selected brief list (see Fig. 1 ) does not do justice to the many excellent apps not mentioned and the teams behind each one mentioned. FOCUS (Ben-Zeev et al., 2019) from Dr. Dror Ben-Zeev, and PRIME (Schlosser et al., 2018) from Dr. Danielle Schlosser, Intellicare from Dr. David Mohr (Mohr et al., 2017), and CBT2Go (Depp et al., 2019) from Dr. Colin Depp as just some examples of mobile health tools for SMI. Using digital phenotyping and smartphone surveys/sensors to better monitor patients' real time, longitudinal, and dynamic experience of mental health is feasible with apps like mindLAMP from our group (Torous et al., 2019), Cross Check from Dr. John Kane (Ben-Zeev et al., 2017) and many others like the MONARCHA by Dr. Jakob Bardram plus many more (Bardram and Mati, 2020) These smartphone digital data streams can be used predict relapse (Barnett et al., 2018), and create personalized care plans responsive to the psychological and social environments of patients. Many commercial apps like Stop Breath and Think (Athanas et al., 2019) offer provide real-time interventions for anxiety that can be of help in addressing the widespread anxiety reactions generated by Covid-19 like crises. The United States Department of Veterans' Affairs offers a library of free mental health apps for anyone to use and benefit from. Finally, the ability to connect and access peer support via apps like PeerTech from Dr. Karen Fortuna (Fortuna et al., 2019) highlights yet another area of rapid expansion potentially addressing the negative consequences of social distancing (Fortuna et al., 2019). This select list covers only a fraction of the many impressive app efforts in SMI.
Fig. 1

Many apps applicable for SMI exist. These selected examples from those mentioned in the text and found on the Android app store on March 24th, 2020: (from top left to bottom right): CBT2GO, PRIME, Intellicare, CBT-I Coach (VA), T2 Mood Tracker (VA), PeerTech, Stop Breath and Think, mindLAMP, Mindfulness Coach (VA), and Virtual Hopebox (VA).

Many apps applicable for SMI exist. These selected examples from those mentioned in the text and found on the Android app store on March 24th, 2020: (from top left to bottom right): CBT2GO, PRIME, Intellicare, CBT-I Coach (VA), T2 Mood Tracker (VA), PeerTech, Stop Breath and Think, mindLAMP, Mindfulness Coach (VA), and Virtual Hopebox (VA). Harnessing these exciting mobile health developments in schizophrenia to help patients today is both an issue of access as well as of awareness and implementation. There is an urgent need to train clinicians about mobile health and reduce workflow barriers to digital health. Our group has piloted a new team member, the digital navigator (Wisniewski et al., 2019), to help bridge the clinical and digital worlds and serve as the ‘glue’ to help complete the link. Some patients will also need help with digital literacy skills and competencies in order to optimally access telehealth and apps. Specifically designed for patients with serious mental illness, our group has piloted a 6 to 8-week group training to equip patients with the ability to confidently navigate the digital world (Hoffman et al., 2020). These two efforts are not headline grabbing artificial intelligence or machine learning projects but the practical foundation the field must invest in today to ensure access and equity. Digital health also brings novel risks that the field must now consider and work to minimize. Today too often patients using mobile health tools are asked to forsake their privacy to open an app and must first agree to a privacy policy written at a college reading level. The problem is worse for mental health apps which have one of the highest rates of failing to offer even the presence of a privacy policy compared to other medical conditions (Wisniewski et al., 2019) Many commercial apps for SMI, the ones patients access today, lack evidence or even adherence to agreed upon standards. At the time of this writing the third search result in the iTunes app store for schizophrenia is an action “game that will make you lose your mind” – a stigmatizing and unhelpful app for anyone. The idea of using mobile technology like apps for global mental health is not new but today that idea is becoming reality for SMI. The early experiences with COVID-19 have forged that reality and now demand healthcare systems seek to rapidly keep up with the technology needs of patients. Schizophrenia already has a legacy of leadership and innovation in mobile mental health and in the near future the transformation, spurred by the COVID-19 crisis will accelerate until mobile and tele- digital health compliment if not challenge the standard of care.

Disclosure

Drs. Torous and Keshavan received grant support from the Natalia Foundation to develop the mindLAMP platform.
  19 in total

1.  Digital Opportunities for Outcomes in Recovery Services (DOORS): A Pragmatic Hands-On Group Approach Toward Increasing Digital Health and Smartphone Competencies, Autonomy, Relatedness, and Alliance for Those With Serious Mental Illness.

Authors:  Liza Hoffman; Hannah Wisniewski; Ryan Hays; Philip Henson; Aditya Vaidyam; Victoria Hendel; Matcheri Keshavan; John Torous
Journal:  J Psychiatr Pract       Date:  2020-03       Impact factor: 1.325

2.  CrossCheck: Integrating self-report, behavioral sensing, and smartphone use to identify digital indicators of psychotic relapse.

Authors:  Dror Ben-Zeev; Rachel Brian; Rui Wang; Weichen Wang; Andrew T Campbell; Min S H Aung; Michael Merrill; Vincent W S Tseng; Tanzeem Choudhury; Marta Hauser; John M Kane; Emily A Scherer
Journal:  Psychiatr Rehabil J       Date:  2017-04-03

3.  Stress and coping responses to a natural disaster in people with schizophrenia.

Authors:  William P Horan; Joseph Ventura; Jim Mintz; Alex Kopelowicz; Donna Wirshing; Jennifer Christian-Herman; David Foy; Robert P Liberman
Journal:  Psychiatry Res       Date:  2007-03-23       Impact factor: 3.222

4.  Efficacy of PRIME, a Mobile App Intervention Designed to Improve Motivation in Young People With Schizophrenia.

Authors:  Danielle A Schlosser; Timothy R Campellone; Brandy Truong; Kevin Etter; Silvia Vergani; Kiya Komaiko; Sophia Vinogradov
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

5.  IntelliCare: An Eclectic, Skills-Based App Suite for the Treatment of Depression and Anxiety.

Authors:  David C Mohr; Kathryn Noth Tomasino; Emily G Lattie; Hannah L Palac; Mary J Kwasny; Kenneth Weingardt; Chris J Karr; Susan M Kaiser; Rebecca C Rossom; Leland R Bardsley; Lauren Caccamo; Colleen Stiles-Shields; Stephen M Schueller
Journal:  J Med Internet Res       Date:  2017-01-05       Impact factor: 5.428

6.  Treatment Compliance in the Long-Term Paranoid Schizophrenia Telemedicine Study.

Authors:  Marek Krzystanek; Krzysztof Krysta; Katarzyna Skałacka
Journal:  J Technol Behav Sci       Date:  2017-05-18

7.  Mental Health Mobile Phone App Usage, Concerns, and Benefits Among Psychiatric Outpatients: Comparative Survey Study.

Authors:  John Torous; Hannah Wisniewski; Gang Liu; Matcheri Keshavan
Journal:  JMIR Ment Health       Date:  2018-11-16

8.  Premature Death of a Schizophrenic Patient due to Evacuation after a Nuclear Disaster in Fukushima.

Authors:  Yuki Sonoda; Akihiko Ozaki; Arinobu Hori; Asaka Higuchi; Yuki Shimada; Kana Yamamoto; Tomohiro Morita; Toyoaki Sawano; Claire Leppold; Masaharu Tsubokura
Journal:  Case Rep Psychiatry       Date:  2019-04-07

9.  Understanding the quality, effectiveness and attributes of top-rated smartphone health apps.

Authors:  Hannah Wisniewski; Gang Liu; Philip Henson; Aditya Vaidyam; Narissa Karima Hajratalli; Jukka-Pekka Onnela; John Torous
Journal:  Evid Based Ment Health       Date:  2019-01-11

10.  Online mental health services in China during the COVID-19 outbreak.

Authors:  Shuai Liu; Lulu Yang; Chenxi Zhang; Yu-Tao Xiang; Zhongchun Liu; Shaohua Hu; Bin Zhang
Journal:  Lancet Psychiatry       Date:  2020-02-19       Impact factor: 27.083

View more
  29 in total

1.  Peer Support Specialists and Service Users' Perspectives on Privacy, Confidentiality, and Security of Digital Mental Health.

Authors:  Maria D Venegas; Jessica M Brooks; Amanda L Myers; Marianne Storm; Karen L Fortuna
Journal:  IEEE Pervasive Comput       Date:  2022-03-01       Impact factor: 1.603

Review 2.  Hybrid and Remote Psychosocial Interventions Focused on Weight and Sedentary Behavior Management Among Patients with Severe Mental Illnesses: a Systematic Review.

Authors:  Ana Cecília Novaes Oliveira; Suzana Maria Menezes Guariente; Robson Zazula; Arthur Eumann Mesas; Carlos Eduardo Coral Oliveira; Edna Maria Vissosi Reiche; Sandra Odebrecht Vargas Nunes
Journal:  Psychiatr Q       Date:  2022-06-24

3.  Impact of the COVID-19 Pandemic on Healthcare Resource Utilization in Individuals with Major Depressive Disorder.

Authors:  Joshua N Liberman; Sandipan Bhattacharjee; Pinyao Rui; Charles Ruetsch; Brian Rothman; Amit Kulkarni; Felicia Forma
Journal:  Health Serv Res Manag Epidemiol       Date:  2022-07-06

4.  Answering the Challenge of COVID-19 Pandemic Through Innovation and Ingenuity.

Authors:  Kathryn Clare Kelley; Jonathan Kamler; Manish Garg; Stanislaw P Stawicki
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Client, clinician, and administrator factors associated with the successful acceptance of a telehealth comprehensive recovery service: A mixed methods study.

Authors:  David A Lynch; Ana Stefancic; Leopoldo J Cabassa; Alice Medalia
Journal:  Psychiatry Res       Date:  2021-03-15       Impact factor: 11.225

6.  Feasibility and acceptability of remotely accessed cognitive remediation for schizophrenia in public health settings.

Authors:  Alice Medalia; Alice M Saperstein; Ana Stefancic; Shanique Meyler; Sarah Styke; Min Qian; Jun Liu; Leopoldo J Cabassa
Journal:  Psychiatry Res       Date:  2021-04-21       Impact factor: 11.225

7.  Implementation case study: Multifamily group intervention in first-episode psychosis programs.

Authors:  Julia Browne; A Simone Sanders; Michelle Friedman-Yakoobian; Margaret Guyer; Matcheri Keshavan; Bo Kim; Emily Kline
Journal:  Early Interv Psychiatry       Date:  2020-11-08       Impact factor: 2.721

8.  Further Adaptations and Reflections by an Assertive Community Treatment Team to Serve Clients with Severe Mental Illness During COVID-19.

Authors:  Greg P Couser; Monica Taylor-Desir; Susan Lewis; Tehillah Joy Griesbach
Journal:  Community Ment Health J       Date:  2021-06-19

9.  Health Apps for Combating COVID-19: Descriptive Review and Taxonomy.

Authors:  Manal Almalki; Anna Giannicchi
Journal:  JMIR Mhealth Uhealth       Date:  2021-03-02       Impact factor: 4.773

10.  Engagement with a digital therapeutic for smoking cessation designed for persons with psychiatric illness fully mediates smoking outcomes in a pilot randomized controlled trial.

Authors:  Julia Browne; Tate F Halverson; Roger Vilardaga
Journal:  Transl Behav Med       Date:  2021-09-15       Impact factor: 3.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.